Sort
326,823 grants matching “clinical trial”
MECHANISMS AND MODULATION OF ACCELLULAR HbA TOXICITY
$2,274,339Joel M Friedman · Albert Einstein College Of Medicine · P01 · FY2012 · HL
Hepatobiology and Toxicology COBRE
$2,274,291Craig J McClain · University Of Louisville · P20 · FY2023 · GM
Cancer Center Support Grant
$2,274,288Mary C. Beckerle · University Of Utah · P30 · FY2016 · CA
Genetics and Genomics of Leiomyosarcoma (LMS): Improved understanding of cancer biology and new approaches to diagnosis and treatment
$2,274,206Scott Michael Schuetze · University Of Michigan At Ann Arbor · P50 · FY2023 · CA
Pharmacogenomics of Anti-platlet Intervention-2 (PAPI-2) Study
$2,274,061Alan R. Shuldiner · University Of Maryland Baltimore · U01 · FY2013 · HL
Program Project â Improving Provider Announcement Communication Training (IMPACT)
$2,273,914Noel Todd Brewer · Univ Of North Carolina Chapel Hill · P01 · FY2024 · CA
Cancer Center Support Grant
$2,273,410Roy A. Jensen · University Of Kansas Medical Center · P30 · FY2019 · CA
COVID-19: Clinical Research Products Management Center (CRPMC)
$2,273,031Carina Remgsamai-Nhe · Fisher Bioservices, Inc. · N01 · FY2021 · AI
SPORE in Gastrointestinal Cancers
$2,273,000Alison P Klein · Johns Hopkins University · P50 · FY2021 · CA
Administrative Core
$2,272,973Sally Lynn Hodder · West Virginia University · U54 · FY2023 · GM
Storage and Distribution of Clinical Agents
$2,272,833Young Kim · Fisher Bioservices, Inc. · N02 · FY2011 · CA
A vaccine design to induce protective B and T cell immunity against hepatitis C virus
$2,272,798Steven Foung · Stanford University · U19 · FY2024 · AI
The Military HIV Research Program (MHRP) Clinical Trial Unit
$2,272,671Merlin L Robb · Henry M. Jackson Fdn For The Adv Mil/Med · UM1 · FY2021 · AI
Comprehensive multimodal analysis of patients with neuroimmunological diseases
$2,272,642Bibiana Bielekova · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Cancer Center Support Grant
$2,272,619Roy A. Jensen · University Of Kansas Medical Center · P30 · FY2020 · CA
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
$2,272,601Gary E Rosenthal · University Of Iowa · UL1 · FY2010 · RR
Mayo Clinic Breast Cancer SPORE
$2,272,470Matthew Philip Goetz · Mayo Clinic Rochester · P50 · FY2019 · CA
Preclinical drug development in pancreatic cancer
$2,272,436Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease
$2,272,422Bin Zhang · Icahn School Of Medicine At Mount Sinai · U01 · FY2022 · AG
UCLA SPORE IN PROSTATE CANCER
$2,272,378University Of California Los Angeles · P50 · FY2003 · CA
UCLA SPORE IN PROSTATE CANCER
$2,272,341University Of California Los Angeles · P50 · FY2004 · CA
Neutralizing Antibody & AAV FIX Gene Therapy
$2,272,304Richard J Samulski · Univ Of North Carolina Chapel Hill · P01 · FY2015 · HL
SPORE in Brain Cancer
$2,272,282Duke University · P50 · FY2005 · CA
DNA Sequencing and FACS Core Facilities
$2,272,032Paul Robbins · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA
Center for the Development of Phenotype-Based Treatments of Autism Spectrum Disorder
$2,271,960David G Amaral · University Of California At Davis · P50 · FY2021 · HD